THE INCIDENCE OF RECURRENCE AND HYPOTHYROIDISM FOLLOWING TREATMENT WITH ANTITHYROID DRUGS, SURGERY OR RADIOIODINE IN ALL PATIENTS WITH THYROTOXICOSIS IN MALMO DURING THE PERIOD 1970-1974

被引:40
作者
BERGLUND, J [1 ]
CHRISTENSEN, SB [1 ]
DYMLING, JF [1 ]
HALLENGREN, B [1 ]
机构
[1] UNIV LUND,MALMO GEN HOSP,DEPT ENDOCRINOL,S-21401 MALMO,SWEDEN
关键词
DRUG THERAPY; GRAVES THYROTOXICOSIS; HYPOTHYROIDISM; RADIOIODINE THERAPY; RECURRENCE; SOLITARY TOXIC ADENOMA; SURGERY; TOXIC MULTINODULAR GOITER;
D O I
10.1111/j.1365-2796.1991.tb00371.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The incidence of recurrence and of hypothyroidism was determined in all new patients treated for thyrotoxicosis during the period 1970-1974 in an unselected, well-defined urban population. A total of 309 patients were followed up for a median time period of 108 (1-192) months. There was a cumulative incidence of 51 % recurrence in patients who were treated with antithyroid drugs for Graves' thyrotoxicosis, whereas after surgery or radioiodine treatment there were few recurrences, but 32 % and 78 % cumulative incidences of hypothyroidism. There were no recurrences after surgery or radioiodine treatment in patients with toxic multinodular goitre or solitary toxic adenoma, but 29 % and 40 % cumulative incidences of hypothyroidism following radioiodine treatment. Late hypothyroidism occurred after surgery for Graves' thyrotoxicosis, and in all groups treated with radioiodine. Thus it is advisable that all patients with Graves' thyrotoxicosis, regardless of treatment, and all patients with toxic multinodular goitre or solitary toxic adenoma treated with radioiodine, should be followed by for many years, and probably for life.
引用
收藏
页码:435 / 442
页数:8
相关论文
共 46 条
[1]   TOTAL AND AGE-SPECIFIC INCIDENCE OF GRAVES THYROTOXICOSIS, TOXIC NODULAR GOITER AND SOLITARY TOXIC ADENOMA IN MALMO 1970-74 [J].
BERGLUND, J ;
CHRISTENSEN, SB ;
HALLENGREN, B .
JOURNAL OF INTERNAL MEDICINE, 1990, 227 (02) :137-141
[2]  
BERKSON J, 1950, P STAFF M MAYO CLIN, V25, P270
[3]  
BLICHERTTOFT M, 1977, ACTA CHIR SCAND, V143, P221
[4]   I-131 TREATMENT OF DIFFUSE AND NODULAR TOXIC GOITER WITH OR WITHOUT ANTITHYROID AGENTS [J].
BLIDDAL, H ;
HANSEN, JM ;
ROGOWSKI, P ;
JOHANSEN, K ;
FRIIS, T ;
SIERSBAEKNIELSEN, K .
ACTA ENDOCRINOLOGICA, 1982, 99 (04) :517-521
[5]  
BURGI H, 1986, SCHWEIZ MED WSCHR, V116, P162
[6]  
CORTENS F, 1984, NEW ENGL J MED, V310, P1393
[7]  
ERICSSON UB, 1981, ACTA MED SCAND, V209, P293
[8]  
FONTANA B, 1980, J NUCL MED ALLIED S, V24, P85
[9]  
GIMLETTE TMD, 1988, NUKLEARMED, V27, P135
[10]   FOLLOW-UP OF SOLITARY AUTONOMOUS THYROID-NODULES TREATED WITH I-131 [J].
GOLDSTEIN, R ;
HART, IR .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (24) :1473-1476